Start with what you notice

BOTOX, in human terms.

Point to the thing you want to change. We will tell you where BOTOX Cosmetic fits, where the use is off-label, and when a different answer should come first.

Trusted product994 FDA-approved cosmetic areasTemporary, not instantly reversible
Short answerThere is one complete product profile.

Each concern below is its own decision branch because the muscle, goal, tradeoffs, approval status, and alternatives change by area.

Current FDA label
What are you trying to change?

Choose the sentence that sounds like you.

No anatomy vocabulary required. You can change your answer at any time.

FDA-approved use

Crow's feet

Moderate to severe lateral canthal lines

This is an exact BOTOX Cosmetic indication when the lines are driven by the muscle around the eye at full smile. It can soften the radiating lines without asking you to stop smiling; dose and placement determine how much movement remains.

Could help with

  • Dynamic lines beside the eyes at full smile
  • A softer eye-area expression
  • Repeated muscle folding while the product is active

Will not automatically fix

  • Under-eye hollows or bags
  • Brown or blue discoloration
  • All crepey texture or static lines
First changeOften noticeable within days; evaluate after it settlesHow longTemporary; the exact product record covers labeled outcomes and timing
See the kind of change people mean

Illustrative before-and-after simulations

These are fictional, AI-created people. They demonstrate a subtle direction of change, not a promised or predicted result.

AI-created side-by-side illustration of a fictional smiling person with crow's feet before and with subtly softened lines afterAI simulation - not a real patient
Before simulationAfter simulation
Crow's feet at full smileSame expression, with lines softened rather than erased.
AI-created side-by-side illustration of a fictional person raising their brows with forehead lines before and subtly softened lines afterAI simulation - not a real patient
Before simulationAfter simulation
Forehead and frown movementA restrained example with some expression retained.

AI can create visual inconsistencies and cannot model your anatomy, dose, injector, healing, or result. Real treatment decisions must use an in-person assessment and authenticated patient photography when available.

Make the consult feel like yours

What should the provider know before talking technique?

Your starting note

I am exploring BOTOX Cosmetic for crow's feet. My priorities: keep some movement. FDA-approved use: The exact area is included in the current U.S. BOTOX Cosmetic label. I want an assessment before deciding on treatment, dose, placement, or timing. Questions I want answered: 1. Are my lines dynamic, static, or mixed? 2. How much smile movement will remain? 3. How often do you treat this exact eye area?

See MedBeautyLA
Current U.S. cosmetic label4 approved areas in adults
Frown linesCrow's feetForehead linesPlatysma bands
Looking for migraine, sweating, muscle spasm, or bladder treatment?

That is medical BOTOX, not this cosmetic decision path.

The same nonproprietary ingredient can appear under separate indications and prescribing information. This page does not turn those conditions into med-spa services.

Independent trust review · spa-trust-1.0

Trusted product

This product record passed every critical evidence and disclosure gate.

99of 10085 required
5/5 gates passedReviewed Jul 15, 2026Valid until Jan 11, 2027
See validation gates and evidence
Exact product identified

The record identifies BOTOX Cosmetic (onabotulinumtoxinA), not a generic or interchangeable toxin.

Required gate · 1 receipt
pass
Regulatory status verified

The current FDA prescribing information revised October 2024 is attached and identifies the exact biologic.

Required gate · 1 receipt
pass
Approved indications bounded

The profile limits approval claims to adult glabellar lines, lateral canthal lines, forehead lines, and platysma bands, while visibly labeling other explored uses as off-label or assessment-first.

Required gate · 1 receipt
pass
Safety labeling attached

The current full prescribing information includes the boxed warning, contraindications, eye risks, interactions, pregnancy, lactation, and pediatric boundaries.

Required gate · 1 receipt
pass
Current source review

Regulatory and manufacturer evidence was reviewed within the active trust window.

Required gate · 4 receipts
pass
Exact product identity100

Manufacturer, nonproprietary name, composition, route, and current indications are explicit.

Regulatory verification100

The FDA approval letter and current prescribing information are attached.

Labeling completeness99

Current indications, dosing boundary, contraindications, warnings, interactions, and population limits are included.

Product-specific evidence97

The clinical evidence remains tied to BOTOX Cosmetic and area-specific studies rather than being transferred from the neuromodulator class.

Safety disclosure99

The boxed warning, expected effects, eye-specific risks, and urgent symptoms are preserved.

Source traceability98

Product claims resolve to regulator or manufacturer receipts.

What this does not mean

  • FDA approval does not make BOTOX Cosmetic appropriate for every concern, person, dose, treatment area, or aesthetic goal.
  • BOTOX Cosmetic Units are product-specific and cannot be compared with or converted into Units of another botulinum toxin.
  • Product trust does not validate a clinic's inventory, injector, placement, price, follow-up, or outcomes.
  • Lip flip, gummy smile, bunny lines, mouth-corner treatment, masseter slimming, and TMJ symptom treatment are not included in the current FDA-approved BOTOX Cosmetic indications.
  • AI simulations on the profile are fictional educational illustrations, not real patients, predictions, or evidence of an individual outcome.
Open the technical record when you want it

Product, safety, and evidence details

What is verified

The current FDA prescribing information verifies four adult cosmetic indications and preserves area-specific dosing, administration, clinical-study, contraindication, warning, and adverse-reaction boundaries.

Exact product
BOTOX Cosmetic (OnabotulinumtoxinA neuromodulator)
Manufacturer
Allergan Aesthetics, an AbbVie company
Access
Prescription biologic administered by a licensed, trained clinician

Safety boundary

In two crow's-feet trials, eyelid edema occurred in 1% of BOTOX Cosmetic participants versus 0% with placebo. The boxed warning and post-market safety sections preserve rare but serious risks even when labeled cosmetic use is common.

Common and expected

  • Needle-site discomfort or pain
  • Bruising or bleeding
  • Localized swelling or redness
  • Eyelid edema; 1% in lateral-canthal-line trials

Rare but serious

  • Distant spread of toxin effect
  • Problems swallowing, speaking, or breathing
  • Generalized muscle weakness
  • Serious allergic reaction
  • Corneal exposure or ulceration related to reduced blinking
  • Life-threatening respiratory or swallowing complications, including reported deaths

Not interchangeable

  • FDA approval does not make BOTOX Cosmetic appropriate for every concern, person, dose, treatment area, or aesthetic goal.
  • BOTOX Cosmetic Units are product-specific and cannot be compared with or converted into Units of another botulinum toxin.
  • Product trust does not validate a clinic's inventory, injector, placement, price, follow-up, or outcomes.
  • Lip flip, gummy smile, bunny lines, mouth-corner treatment, masseter slimming, and TMJ symptom treatment are not included in the current FDA-approved BOTOX Cosmetic indications.
  • AI simulations on the profile are fictional educational illustrations, not real patients, predictions, or evidence of an individual outcome.

Do not use

  • Known hypersensitivity to any botulinum toxin preparation or any formulation component
  • Infection at a proposed injection site
See the exact crow's-feet record
Source ledger

4 product receipts

BOTOX Cosmetic Prescribing InformationU.S. Food and Drug Administration - Reviewed 2026-07-15BOTOX Cosmetic Lateral Canthal Lines Supplement ApprovalU.S. Food and Drug Administration - Reviewed 2026-07-15BOTOX Cosmetic Questions and AnswersAllergan Aesthetics, an AbbVie company - Reviewed 2026-07-15BOTOX Cosmetic Crow's Feet ResultsAllergan Aesthetics, an AbbVie company - Reviewed 2026-07-15

Educational decision support, not medical advice, diagnosis, dosing guidance, or an outcome guarantee. Approval status applies to the exact product, area, population, and label; a qualified clinician still has to assess personal fit.